TY  - JOUR

T1  - Assessing the long-term effectiveness of cladribine vs. placebo in the relapsing-remitting multiple sclerosis CLARITY randomized controlled trial and CLARITY Extension using treatment switching adjustment methods

JO  - Advances in Therapy

UR  - http://eprints.whiterose.ac.uk/153094/

PY  - 2019/11/07

AU  - Bell Gorrod H

AU  - Latimer N

AU  - Damian D

AU  - Hettle R

AU  - Harty GT

AU  - Wong SL

ED  - 

DO  - DOI: 10.1007/s12325-019-01140-z

PB  - Springer (part of Springer Nature)

Y2  - 2024/12/22

ER  -